Posted by 
ABBVIE ESSENTIALLY BRIBES IRISH DOCTORS TO PRESCRIBE PUBERTY BLOCKERS (MINISTER HELEN MC ENTEE’S HUSBAND IS A SENIOR EXECUTIVE) AbbVie “paid” out more than any other pharmaceutical company to “influence” [BRIBE] healthcare professionals to prescribe their products. This has emerged after the not so shocking news broke that a study shows big pharma make “widespread” payments to Irish healthcare professionals (over €14 million alone in 2023) to prescribe their products. When those who refused the c○v!d experimental prophylactic pointed out previously that this is common practice (doctors being swayed with bribes) we were labelled “conspiracy theorists.” AbbVie is one of the biggest manufacturers of puberty blockers in the world, and Minister Helen McEntee is the director of “market access” at the firm. Perhaps nothing gives better marker access than essentially giving bribes (in all but name) to “healthcare professionals”? The company paid out almost €900,000 to “educate” those who received the payments (those who then subsequently pushed puberty blockers). €900,000 is, of course, only loose change for the pharma giant. Abbvie’s drug Lupron is used as a puberty blocker, and the company saw €892 million dollars worth of sales in 2019. Gript has reported AbbVie is being investigated by the State of Texas for its role in manufacturing and promoting these drugs, which are highly damaging to vulnerable children and can cause infertility and other health issues. AbbVie loses serious profits every time a country bans the use of puberty blockers in children, as has recently happened in the UK, and as is happening in many US States. There’s no sign of this happening anytime soon in the Republic of Ireland, however. Data analysis for 2023 for the study shows that drug companies in Ireland made 4,509 payments to healthcare professionals and healthcare organisations, amounting to over €14.4m that year. The highest individual payment during the year by a drug company was €50,462 to a medical practitioner. There were 3,508 payments to healthcare professionals, amounting to €5.5m and 64 payments that exceeded €8,000. According to
(who pretended they never knew any of this), the review was conducted by Professor Michael Barry, Clinical Director of the National Centre for Pharmacoeconomics, which conducts assessments on the cost effectiveness of medicines for the HSE to consider, when making decisions on whether medicines should be made available for the public system. In his review of the 2023 payments, Prof Barry said drug companies fund many healthcare settings, like hospitals and universities, where education and professional development take place. The industry also funds some medical societies. Prof Barry said the concern is not only are some societies involved in the education, research and development of prescribers, but some may also be involved in generating treatment guidelines. The payments by companies are publicly disclosed in accordance with the Irish Pharmaceutical Healthcare Association (IPHA) code of practice since 2016. The details on the public website http://transferofvalue.ie come from up to 50 companies, including non-IPHA members. The payments are officially called “Transfer of Value.” The company that made the greatest number of payments to healthcare professionals was Novartis, with 374 such payments but AbbVie paid the highest to healthcare professionals. Prof Barry said that many would consider that the pharmaceutical industry should not have any role in the “education of healthcare professionals and prescribers.” He said that the medical literature has highlighted that doctors with ties to industry may be more inclined than their colleagues to prescribe a brand name drug, despite the availability of a cheaper generic version. Now, after reading this do you still trust your doctor or consultant quite as much?
·
21.2K Views
Who Watches the Watchers? 